Inhibition of HBsAg secretion by a novel autophagy inducer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F24%3A10477360" target="_blank" >RIV/00216208:11310/24:10477360 - isvavai.cz</a>
Result on the web
<a href="https://www.virology.cz/" target="_blank" >https://www.virology.cz/</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Inhibition of HBsAg secretion by a novel autophagy inducer
Original language description
Chronic hepatitis B (CHB) is a viral liver infection caused by hepatitis B virus (HBV), affecting over 300 million people world-wide. Untreated CHB can lead to liver cirrhosis and hepatocellular carcinoma, causing over 800,000 deaths annually. Current nucleot(s)ide analogue-based therapies effectively slow disease progression and reduce viral load, but require life-long application. Pegylated interferon alpha therapy clears the virus in a small percentage of patients, but has serious side effects. Therefore, a universally effective and definitive cure of CHB is still elusive.
Czech name
—
Czech description
—

Project
<a href="/en/project/LX22NPO5103" target="_blank" >LX22NPO5103: National Institute of Virology and Bacteriology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)